UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma

Immunotherapy, 2017-12, Vol.9 (16), p.1323-1330

2017

Link zum Volltext

Verfügbarkeit prüfen

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma

Cancers, 2020-08, Vol.12 (8), p.2182

2020

Link zum Volltext

Verfügbarkeit prüfen

Photoacoustic detection of metastatic melanoma cells in the human circulatory system

Optics letters, 2006-10, Vol.31 (20), p.2998

2006

Link zum Volltext

Verfügbarkeit prüfen

1244 Polarized immune responses reveal actionable therapeutic targets in cutaneous adverse events to checkpoint inhibitors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1374-A1374

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?

Reviews on recent clinical trials, 2016-06, Vol.11 (2), p.81

2016

Link zum Volltext

Verfügbarkeit prüfen

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells

EBioMedicine, 2015-11, Vol.2 (11), p.1821-1826

2015

Link zum Volltext

Verfügbarkeit prüfen

43858 The 31-gene expression profile test for cutaneous melanoma identifies patients with stage IB- IIA disease who have recurrence risk similar to that of stage IIB-IIC disease

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB230-AB230

2023

Link zum Volltext

Verfügbarkeit prüfen

Optical Photoacoustic Detection of Circulating Melanoma Cells In Vitro

International journal of thermophysics, 2010-05, Vol.31 (4-5), p.784-792

2010

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.AB227

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 trial comparing fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) to pembrolizumab in patients with completely resected high-risk melanoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9598-TPS9598

2023

Link zum Volltext

Verfügbarkeit prüfen

CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world setting

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9614-TPS9614

2023

Link zum Volltext

Verfügbarkeit prüfen

IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience

The American journal of gastroenterology, 2023-09, Vol.118 (9), p.1679-1683

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection of circulating tumor cells by photoacoustic flowmetry

Methods in molecular biology (Clifton, N.J.), 2014, Vol.1102, p.655

2014

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant nivolumab in high-risk stage IIb/IIc melanoma patients: Results from investigator initiated clinical trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9583-9583

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating cell free DNA to predict recurrence in uveal melanoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9569-9569

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of pretreatment steroids on the development of immune related adverse events

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15095-e15095

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of comorbidity on immune checkpoint blockade tolerance across tumor types

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15068-e15068

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of age on immune checkpoint blockade tolerability across malignancies: A single institution review

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15069-e15069

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 471: Detection of circulating tumor cells in high-risk primary uveal melanoma by the photoacoustic method

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.471-471

2016

Link zum Volltext

Verfügbarkeit prüfen

Thyroid-related laboratory abnormalities to predict treatment-limiting adverse events in melanoma patients treated with immune checkpoint blockade

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14536-e14536

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT144: Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT144-CT144

2018

Link zum Volltext

Verfügbarkeit prüfen

Liver-directed treatment for patients with uveal melanoma hepatic metastasis: A retrospective analysis of overall survival

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.9592-9592

2018

Link zum Volltext

Verfügbarkeit prüfen

Resolution of pre-cancerous and non-melanoma skin cancers after immune checkpoint inhibitor treatments

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14540-e14540

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 384: Detection of circulating melanoma cells in paired arterial and venous specimens from uveal melanoma patients with hepatic metastatic

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.384-384

2015

Link zum Volltext

Verfügbarkeit prüfen

Estimating and benchmarking Less-than-Truckload market rates

Transportation research. Part E, Logistics and transportation review, 2010-09, Vol.46 (5), p.667-682

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(46)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(15)
Humans
(13)
Male
(6)
Urology & Nephrology
(5)
Adult
(4)
Aged
(4)
Female
(4)
Melanoma
(4)
Middle Aged
(4)
Oncology
(4)
Retrospective Studies
(4)
Cancer
(3)
Engineering
(3)
Neoplastic Cells, Circulating - Pathology
(3)
Patients
(3)
Technology
(3)
Treatment Outcome
(3)
Apoptosis
(2)
Cancer Detection
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma

Photoacoustic detection of metastatic melanoma cells in the human circulatory system

1244 Polarized immune responses reveal actionable therapeutic targets in cutaneous adverse events to checkpoint inhibitors

Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells

43858 The 31-gene expression profile test for cutaneous melanoma identifies patients with stage IB- IIA disease who have recurrence risk similar to that of stage IIB-IIC disease

Optical Photoacoustic Detection of Circulating Melanoma Cells In Vitro

Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses

A phase 3 trial comparing fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) to pembrolizumab in patients with completely resected high-risk melanoma

CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world setting

IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience

Detection of circulating tumor cells by photoacoustic flowmetry

Adjuvant nivolumab in high-risk stage IIb/IIc melanoma patients: Results from investigator initiated clinical trial

Circulating cell free DNA to predict recurrence in uveal melanoma

Effect of pretreatment steroids on the development of immune related adverse events

Impact of comorbidity on immune checkpoint blockade tolerance across tumor types

Impact of age on immune checkpoint blockade tolerability across malignancies: A single institution review

Abstract 471: Detection of circulating tumor cells in high-risk primary uveal melanoma by the photoacoustic method

Thyroid-related laboratory abnormalities to predict treatment-limiting adverse events in melanoma patients treated with immune checkpoint blockade

Abstract CT144: Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma

Liver-directed treatment for patients with uveal melanoma hepatic metastasis: A retrospective analysis of overall survival

Resolution of pre-cancerous and non-melanoma skin cancers after immune checkpoint inhibitor treatments

Abstract 384: Detection of circulating melanoma cells in paired arterial and venous specimens from uveal melanoma patients with hepatic metastatic

Estimating and benchmarking Less-than-Truckload market rates

Suchergebnisse filtern